loceryl has been researched along with triazoles in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| McCormack, JG; Seow, WK; Thong, YH; Vuddhakul, V | 1 |
| Gugnani, HC; Okeke, CN | 1 |
| Espinel-Ingroff, A; Gebhart, RJ; Shadomy, S | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Espinel-Ingroff, A; Kerkering, TM; Shadomy, S | 1 |
| Hiratani, T; Yamaguchi, H | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Kakehi, K; Senda, H; Tatsumi, Y; Yokoo, M | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y | 1 |
| Lipner, S; Scher, RK | 1 |
| Hossin, B; Murdan, S; Rizi, K | 1 |
| Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
2 review(s) available for loceryl and triazoles
| Article | Year |
|---|---|
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
12 other study(ies) available for loceryl and triazoles
| Article | Year |
|---|---|
Effects of the newer antifungal agents (bifonazole, ICI 195, 739 and amorolfin) on in vitro phagocytic, lymphocytic and natural-killer cell responses.
Topics: Antifungal Agents; Humans; Imidazoles; In Vitro Techniques; Killer Cells, Natural; Lymphocyte Activation; Lymphocytes; Morpholines; Neutrophils; Phagocytosis; Triazoles | 1989 |
In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.
Topics: Animals; Antifungal Agents; Culture Media; Econazole; Fungi; Imidazoles; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests; Morpholines; Thiabendazole; Triazoles | 1987 |
In vitro studies with R 51,211 (itraconazole).
Topics: Antifungal Agents; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Morpholines; Triazoles | 1984 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
Topics: Antifungal Agents; Arthrodermataceae; Blastomyces; Candida; Coccidioides; Cryptococcus neoformans; Drug Evaluation, Preclinical; Histoplasma; Imidazoles; Ketoconazole; Miconazole; Morpholines; Sporothrix; Triazoles | 1984 |
[Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
Topics: Antifungal Agents; Candida albicans; Depression, Chemical; Drug Resistance, Microbial; Ergosterol; Ketoconazole; Morpholines; Naphthalenes; Terbinafine; Triazoles | 1994 |
Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Guinea Pigs; Male; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis; Triazoles; Trichophyton | 2002 |
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon | 2013 |
Onychomycosis: current and future therapies.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2014 |
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult | 2016 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |